2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
核酸检测
抗体
病毒学
特异性抗体
2019-20冠状病毒爆发
医学
免疫学
核酸
生物
病理
疾病
爆发
传染病(医学专业)
生物化学
作者
Xuehan Li,Jin Zhao,Yunbao Pan,Yirong Li
摘要
With the gradual progress of epidemic prevention and control work, the process of epidemic prevention and control in COVID-19 has entered a critical period. As the main method to diagnose patients with COVID-19,the disadvantages of nucleic acid detection are gradually revealed. As an important immune response product, specific antibodies have been rapidly applied to the laboratory detection of 2019 novel coronavirus (2019-nCoV), combined with nucleic acid detection for rapid diagnosis and screening of patients with COVID-19. This paper explores and discusses the production pattern and common detection methods of 2019-nCoV specific antibodies and the application and limitations of antibody detection in the clinical work to promote the application and development of specific antibody in COVID-19 diagnosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI